• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

33 株慢生长分枝杆菌参考菌株对 19 种抗菌药物的药敏性。

Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents.

机构信息

Department of Immunology, Changzhi Medical College, Changzhi, Shanxi 046000, China.

State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

出版信息

Biomed Res Int. 2017;2017:1584658. doi: 10.1155/2017/1584658. Epub 2017 Apr 20.

DOI:10.1155/2017/1584658
PMID:28512635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5415667/
Abstract

. Slowly growing mycobacteria (SGM) are prevalent worldwide and cause an extensive spectrum of diseases. . In this study, the antimicrobial susceptibility of 33 reference strains of SGM to 19 antimicrobial agents was tested using a modified microdilution method. . Cefmetazole (32/33) and azithromycin (32/33) exhibited the highest antimicrobial activity, and dapsone (9/33) exhibited the lowest activity against the tested strains. Cefoxitin (30/33), cefoperazone (28/33), and cefepime (28/33) were effective against a high proportion of strains, and macrolides were also highly effective as well as offering the benefit of convenient oral administration to patients. Linezolid (27/33), meropenem (26/33), sulfamethoxazole (26/33), and tigecycline (25/33) showed the highest activity; clofazimine (20/33) and doxycycline (18/33) showed intermediate activity; and rifapentine (13/33), rifabutin (13/33), and minocycline (11/33) showed low antimicrobial activity, closely followed by thioacetazone (10/33) and pasiniazid (10/33), against the tested organisms. According to their susceptibility profiles, the slowly growing species and were the least susceptible to the tested drugs, whereas , , , , , and were the most susceptible. . In summary, cephalosporins and macrolides, particularly cefmetazole, azithromycin, clarithromycin, and roxithromycin, showed good antimicrobial activity against the reference strains of SGM.

摘要

.. 缓慢生长分枝杆菌(SGM)在全球广泛存在,可引起广泛的疾病谱。.. 在这项研究中,使用改良微量稀释法测试了 33 株 SGM 参考菌株对 19 种抗菌药物的药敏性。.. 头孢美唑(33/33)和阿奇霉素(33/33)表现出最高的抗菌活性,而磺胺二甲嘧啶(9/33)对测试菌株的活性最低。头孢西丁(30/33)、头孢哌酮(28/33)和头孢吡肟(28/33)对大部分菌株有效,大环内酯类药物也具有高度活性,并且为患者提供了口服给药的便利。利奈唑胺(27/33)、美罗培南(26/33)、磺胺甲噁唑(26/33)和替加环素(25/33)表现出最高的活性;氯法齐明(20/33)和强力霉素(18/33)表现出中等活性;利福喷丁(13/33)、利福布汀(13/33)和米诺环素(11/33)表现出低抗菌活性,紧随其后的是硫代乙酰胺(10/33)和对氨基水杨酸(10/33),对测试的微生物。根据其药敏谱,缓慢生长的种 和 对测试药物的敏感性最低,而 、 、 、 、 和 最敏感。.. 综上所述,头孢菌素类和大环内酯类,特别是头孢美唑、阿奇霉素、克拉霉素和罗红霉素,对 SGM 参考菌株表现出良好的抗菌活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfe/5415667/1a78108e1f9a/BMRI2017-1584658.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfe/5415667/3763d306cd3f/BMRI2017-1584658.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfe/5415667/1a78108e1f9a/BMRI2017-1584658.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfe/5415667/3763d306cd3f/BMRI2017-1584658.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfe/5415667/1a78108e1f9a/BMRI2017-1584658.002.jpg

相似文献

1
Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents.33 株慢生长分枝杆菌参考菌株对 19 种抗菌药物的药敏性。
Biomed Res Int. 2017;2017:1584658. doi: 10.1155/2017/1584658. Epub 2017 Apr 20.
2
Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.中国临床分离株和非结核分枝杆菌参考株对 41 种药物的药敏性和 MIC 分布。
Int J Antimicrob Agents. 2017 Mar;49(3):364-374. doi: 10.1016/j.ijantimicag.2016.10.024. Epub 2016 Dec 21.
3
Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China.31种抗菌药物对中国快速生长分枝杆菌分离株的药敏试验
Biomed Res Int. 2015;2015:419392. doi: 10.1155/2015/419392. Epub 2015 Aug 13.
4
Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.使用Sensititre RAPMYCO检测板评估快速生长分枝杆菌的抗菌药敏性。
New Microbiol. 2012 Jan;35(1):73-6. Epub 2012 Jan 10.
5
Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.新型抗分枝杆菌药物的研发前景,特别提及新型苯并恶嗪利福霉素KRM-1648
Arch Immunol Ther Exp (Warsz). 2000;48(3):183-8.
6
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.采用肉汤微量稀释法MIC系统测定克拉霉素对8种缓慢生长的非结核分枝杆菌的活性。
Antimicrob Agents Chemother. 1992 Sep;36(9):1987-90. doi: 10.1128/AAC.36.9.1987.
7
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
8
Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.司帕沙星与其他八种抗菌药物对非结核分枝杆菌临床分离株的体外活性比较
J Antimicrob Chemother. 1996 Jan;37(1):151-4. doi: 10.1093/jac/37.1.151.
9
In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.某些药物组合在体外对抑制从猫和狗身上分离出的快速生长分枝杆菌的相互作用以及这些分离株对头孢维星和氯法齐明的敏感性。
Aust Vet J. 2015 Jan-Feb;93(1-2):40-5. doi: 10.1111/avj.12279.
10
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].[龟分枝杆菌和脓肿分枝杆菌的药敏分析及Etest药敏试验评估]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):567-71.

引用本文的文献

1
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine.治疗非结核分枝杆菌感染的药物:来自意大利传染病和热带医学学会分枝杆菌研究组的叙述性综述。
Infection. 2024 Jun;52(3):737-765. doi: 10.1007/s15010-024-02183-3. Epub 2024 Feb 8.
2
Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease.口服β-内酰胺类药物联合治疗鸟分枝杆菌复合体肺病。
J Infect Dis. 2024 Aug 16;230(2):e241-e246. doi: 10.1093/infdis/jiad591.
3
Molecular Mechanisms of MmpL3 Function and Inhibition.

本文引用的文献

1
Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera.由偶发分枝杆菌引起的肺部疾病的临床特征及治疗结果
Diagn Microbiol Infect Dis. 2016 Dec;86(4):382-384. doi: 10.1016/j.diagmicrobio.2016.09.016. Epub 2016 Sep 24.
2
Species diversity and molecular characterization of nontuberculous mycobacteria in hospital water system of a developing country, Iran.伊朗一个发展中国家医院供水系统中非结核分枝杆菌的物种多样性和分子特征
Microb Pathog. 2016 Nov;100:62-69. doi: 10.1016/j.micpath.2016.09.004. Epub 2016 Sep 9.
3
Isolation of Nontuberculous Mycobacteria from the Environment of Ghanian Communities Where Buruli Ulcer Is Endemic.
MmpL3 功能和抑制的分子机制。
Microb Drug Resist. 2023 May;29(5):190-212. doi: 10.1089/mdr.2021.0424. Epub 2023 Feb 21.
4
Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.伊朗地区结核病参考实验室分离的生长缓慢非结核分枝杆菌的耐药谱及相关基因突变:一项为期三年的横断面研究。
Pathog Glob Health. 2023 Feb;117(1):52-62. doi: 10.1080/20477724.2022.2049029. Epub 2022 Mar 9.
5
cavitary lung disease progression over a three year period - A case report.三年间空洞性肺病的进展——病例报告
IDCases. 2022 Jan 5;27:e01379. doi: 10.1016/j.idcr.2022.e01379. eCollection 2022.
6
Drug susceptibility distributions of and other non-tuberculous mycobacteria.和其他非结核分枝杆菌的药物敏感性分布情况。
Antimicrob Agents Chemother. 2023 May 1;65(5). doi: 10.1128/AAC.02131-20. Epub 2021 Feb 22.
7
Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in isolates.分离株中与氟喹诺酮和氨基糖苷类耐药性相关的单核苷酸多态性
Infect Drug Resist. 2018 Apr 9;11:515-521. doi: 10.2147/IDR.S160899. eCollection 2018.
从布氏杆菌病流行的加纳社区环境中分离非结核分枝杆菌。
Appl Environ Microbiol. 2016 Jun 30;82(14):4320-4329. doi: 10.1128/AEM.01002-16. Print 2016 Jul 15.
4
Endophthalmitis Caused by Nontuberculous Mycobacterium: Clinical Features, Antimicrobial Susceptibilities, and Treatment Outcomes.非结核分枝杆菌引起的眼内炎:临床特征、抗菌药敏性及治疗结果
Am J Ophthalmol. 2016 Aug;168:150-156. doi: 10.1016/j.ajo.2016.03.035. Epub 2016 Apr 2.
5
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.替加环素在体外增强克拉霉素对鸟分枝杆菌的活性。
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2577-9. doi: 10.1128/AAC.02864-15. Print 2016 Apr.
6
The antimicrobial susceptibility of non-tuberculous mycobacteria.非结核分枝杆菌的抗菌药物敏感性。
J Infect. 2016 Mar;72(3):324-31. doi: 10.1016/j.jinf.2015.12.007. Epub 2015 Dec 24.
7
In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents.40株国际参考快速生长分枝杆菌对20种抗菌药物的体外药敏试验
Int J Clin Exp Med. 2015 Sep 15;8(9):15423-31. eCollection 2015.
8
Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium simiae: The First Reported Case in South Korea.由猿分枝杆菌引起的非结核分枝杆菌肺病:韩国首例报告病例
Tuberc Respir Dis (Seoul). 2015 Oct;78(4):432-5. doi: 10.4046/trd.2015.78.4.432. Epub 2015 Oct 1.
9
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
10
Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China.31种抗菌药物对中国快速生长分枝杆菌分离株的药敏试验
Biomed Res Int. 2015;2015:419392. doi: 10.1155/2015/419392. Epub 2015 Aug 13.